Bio Rad Laboratories Inc operates primarily in the Life Sciences and Clinical Diagnostics industries. As a leading global provider of specialty diagnostic solutions, Bio Rad offers a wide range of products and services for scientific research and healthcare diagnostics. The company specializes in developing and manufacturing instruments, reagents, software, and consumables for applications in life science research, clinical laboratories, and pharmaceutical production. With a focus on advancing scientific discovery and improving patient healthcare, Bio Rad Laboratories Inc plays a crucial role in the fields of molecular biology, genomics, proteomics, and more.

Some of the main competitors of Bio Rad Laboratories Inc in the market include Thermo Fisher Scientific Inc, PerkinElmer Inc, and Illumina Inc.

Bio Rad Laboratories Inc, established in 1952, is a global leader in life science research and clinical diagnostics. The company's rich history spans over several decades, during which it has consistently provided innovative solutions to scientists and healthcare professionals. Bio Rad initially focused on the development of specialized products for the growing field of biochemical research, and later expanded into medical diagnostics and life science technologies. Today, Bio Rad continues to deliver cutting-edge technology, spanning areas such as genomics, proteomics, cell biology, food safety, and more. With a commitment to excellence and advancements in healthcare, Bio Rad Laboratories Inc remains a trusted name in the scientific community.

Bio Rad Laboratories Inc has accomplished several significant milestones. From its inception in 1952, the company has become a global leader in life science research and clinical diagnostics. One noteworthy achievement is the development of ground-breaking products, such as the first digital imaging system for electrophoresis analysis, which revolutionized the field. Bio Rad also played a crucial role in advancing HIV/AIDS diagnostics and monitoring through the introduction of reliable testing systems. Additionally, the company's continuous dedication to innovation has led to expansions in various areas, including food safety and quality control, further strengthening its position as a trusted provider of scientific solutions across industries. Bio Rad Laboratories Inc remains committed to driving advancements and enhancing scientific research globally.

Bio Rad Laboratories Inc is primarily present in the United States, with its headquarters located in Hercules, California. Aside from its domestic presence, Bio Rad operates internationally in various countries and regions. This includes Europe (with offices in the United Kingdom, France, Germany, and other countries), Asia-Pacific (including Japan, China, Korea, and Australia), Latin America, and Canada. With its extensive global footprint, Bio Rad Laboratories Inc continues to expand its reach and serve customers worldwide in the life sciences and clinical diagnostics industries.

Bio Rad Laboratories Inc represents a strong set of values and a dedicated corporate philosophy. The company is committed to providing innovative solutions and high-quality products in the life sciences and clinical diagnostics fields. Bio Rad prioritizes excellence, integrity, and teamwork in all its endeavors. With a focus on customer satisfaction, Bio Rad strives to deliver superior value and support to its clients. The company's relentless dedication to scientific advancement and commitment to ethical and responsible business practices contribute to its reputable standing in the industry.

Analysts currently set an average price target of 362,10 USD for the Bio Rad Laboratories stock (median: 372,30 USD), implying +8,3 % versus the latest price. The consensus is based on 10 analyst ratings.

Bio Rad Laboratories Analyytikkojen kursstavoitteet 2026

10 analysts currently rate the Bio Rad Laboratories stock: 6 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Bio Rad Laboratories to generate revenue of 2,58 Mrd. USD and earnings per share of 9,44 USD.

Bio Rad Laboratories Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Bio Rad Laboratories share trades at 290,14 EUR (334,39 USD).

The Bio Rad Laboratories share (BIO) is listed on 6 stock exchanges, including: NYSE (BIO), XETRA (BUWA.DE), Frankfurt (BUWA.F), München (BUWA.MU), Düsseldorf (BUWA.DU), SIX (Zürich) (BUWA.SW).

Bio Rad Laboratories Inc is a globally operating company in the field of life science research, diagnostics, and biopharmaceuticals. The company offers a wide range of innovative products and services for research institutions, biotechnology and pharmaceutical companies, as well as customers in clinical diagnostics. The business strategy of Bio Rad Laboratories is based on three pillars: product innovation, diversification, and global expansion. The company continuously invests in research and development to develop new products and services that meet the needs of its customers. Thanks to the diversification of its product lines, Bio Rad Laboratories is able to expand in various areas of life sciences and address a wide spectrum of customers. The company is divided into six main business areas: 1. Life Science Research Bio Rad Laboratories offers a comprehensive range of life science research products for research in genomics, proteomics, cell biology, and immunology. Products include DNA isolation kits, PCR reagents, protein separation systems, and antibody solutions. 2. Diagnostics Bio Rad Laboratories is a leading provider of in vitro diagnostics and QC/QA products. The company offers diagnostic products for clinical chemistry, hematology, immunology, and microbiology. 3. Biopharma Bio Rad Laboratories offers a wide range of solutions for biopharmaceuticals, including chromatography columns, protein purification systems, and analysis equipment. 4. Food Science Bio Rad Laboratories offers products for food quality assurance. This includes products for the identification of contaminants in food, such as salmonella, E. coli, and other bacterial contaminations, as well as for testing the nutrient quality in food. 5. Process Separations Bio Rad Laboratories offers a comprehensive range of chromatography columns and accessories used for downstream purification of proteins and other biomolecules in biopharmaceuticals and the food industry. 6. Digital Biology Bio Rad Laboratories offers solutions for digital PCR analysis with its droplet digital PCR technology. This technology allows for the quantification of nucleic acids on an absolute basis and can be used in numerous applications in research and diagnostics. The company also offers software solutions that simplify and standardize data recording and analysis in laboratory tests. The offered software solutions include laboratory information management systems (LIMS), chromatography software, and data analysis tools. Bio Rad Laboratories' customers include research institutions, biotechnology and pharmaceutical companies, as well as customers in clinical diagnostics. The company's products and services are sold in over 100 countries worldwide. In conclusion, Bio Rad Laboratories offers a wide portfolio of products and services in the field of life science research, diagnostics, and biopharmaceuticals. The company pursues a business strategy based on product innovation, diversification, and global expansion. Thanks to the wide range of products and services designed for different business areas, Bio Rad Laboratories is able to serve a broad spectrum of customers worldwide.

odotettu liikevaihto Bio Rad Laboratories on 2,58 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Bio Rad Laboratories on 255,10 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Bio Rad Laboratories:n hinta-voitto-suhde (P/E) on tällä hetkellä 35,41. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Bio Rad Laboratories-osakkeen arvostusta.

Bio Rad Laboratories:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,51. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Bio Rad Laboratories-osakkeen arvostuskennuslukuna.

Bio Rad Laboratories:n Eulpool-laatuscore on 2/10.

Bio Rad Laboratories:n ISIN on US0905722072. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Bio Rad Laboratories:n WKN on 865406. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Bio Rad Laboratories:n ticker on BIO. Tämä pörssinoteeraus käytetään Bio Rad Laboratories-osakkeiden kauppaan pörssissä.

Bio Rad Laboratories maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Bio Rad Laboratories kuuluu sektoriin 'Terveydenhuolto'.

Bio Rad Laboratories:n osingot jaetaan valuutassa USD.